dc.contributor.author |
Sahin, Asena Keles |
|
dc.contributor.author |
Kukner, Ahmet Sahap |
|
dc.contributor.author |
Ulas, Fatih |
|
dc.contributor.author |
Dogan, Umit |
|
dc.date.accessioned |
2024-03-15T12:05:45Z |
|
dc.date.available |
2024-03-15T12:05:45Z |
|
dc.date.issued |
2020 |
|
dc.identifier.citation |
Sahin, AK., Kükner, AS., Ulas, F., Dogan, Ü. (2020). Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema. Int. J. Ophthalmol., 13(12), 1901-1907. https://doi.org/10.18240/ijo.2020.12.09 |
en_US |
dc.identifier.issn |
2222-3959 |
|
dc.identifier.issn |
2227-4898 |
|
dc.identifier.uri |
http://dx.doi.org/10.18240/ijo.2020.12.09 |
|
dc.identifier.uri |
https://www.webofscience.com/wos/woscc/full-record/WOS:000596627600009 |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4629 |
|
dc.description |
WoS Categories: Ophthalmology |
en_US |
dc.description |
Web of Science Index: Science Citation Index Expanded (SCI-EXPANDED) |
en_US |
dc.description |
Research Areas: Ophthalmology |
en_US |
dc.description.abstract |
AIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery. METHODS: Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6. RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005). CONCLUSION: Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
IJO PRESS-XI AN |
en_US |
dc.relation.isversionof |
10.18240/ijo.2020.12.09 |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
cataract surgery, cystoid macular edema, nepafenac, optic coherence tomography, retinal thickness |
en_US |
dc.subject |
NONSTEROIDAL ANTIINFLAMMATORY DRUGS, KETOROLAC 0.4-PERCENT, VISUAL-ACUITY, DEXAMETHASONE, PREVENTION, INFLAMMATION, MANAGEMENT, BROMFENAC, EFFICACY, IMPACT |
en_US |
dc.title |
Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.contributor.authorID |
0000-0003-4468-3985 |
en_US |
dc.identifier.volume |
13 |
en_US |
dc.identifier.issue |
12 |
en_US |
dc.identifier.startpage |
1901 |
en_US |
dc.identifier.endpage |
1907 |
en_US |